These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11145737

  • 21. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K, Shirasawa S, Nishioka M, Sasazuki T.
    Cancer Res; 1999 May 15; 59(10):2445-50. PubMed ID: 10344756
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.
    Bunone G, Briand PA, Miksicek RJ, Picard D.
    EMBO J; 1996 May 01; 15(9):2174-83. PubMed ID: 8641283
    [Abstract] [Full Text] [Related]

  • 25. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
    Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F.
    EMBO J; 1996 Mar 15; 15(6):1292-300. PubMed ID: 8635462
    [Abstract] [Full Text] [Related]

  • 26. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU, Tuyt LM, Lummen C, Wierenga AT, Kruijer W, Vellenga E.
    Br J Pharmacol; 2000 Sep 15; 131(1):99-107. PubMed ID: 10960075
    [Abstract] [Full Text] [Related]

  • 27. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.
    Caelles C, González-Sancho JM, Muñoz A.
    Genes Dev; 1997 Dec 15; 11(24):3351-64. PubMed ID: 9407028
    [Abstract] [Full Text] [Related]

  • 28. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM, Wang IC, Yang JL.
    Carcinogenesis; 2000 Jul 15; 21(7):1423-32. PubMed ID: 10874022
    [Abstract] [Full Text] [Related]

  • 29. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 30. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
    Lee H, Jiang F, Wang Q, Nicosia SV, Yang J, Su B, Bai W.
    Mol Endocrinol; 2000 Nov 15; 14(11):1882-96. PubMed ID: 11075819
    [Abstract] [Full Text] [Related]

  • 31. Blockade of v-Src-stimulated tumor formation by the Src homology 3 domain of Crk-associated substrate (Cas).
    Cheng CH, Yu KC, Chen HL, Chen SY, Huang CH, Chan PC, Wung CW, Chen HC.
    FEBS Lett; 2004 Jan 16; 557(1-3):221-7. PubMed ID: 14741371
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein.
    Rowan BG, Garrison N, Weigel NL, O'Malley BW.
    Mol Cell Biol; 2000 Dec 16; 20(23):8720-30. PubMed ID: 11073973
    [Abstract] [Full Text] [Related]

  • 34. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
    Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S.
    J Biol Chem; 2000 May 26; 275(21):15645-51. PubMed ID: 10747867
    [Abstract] [Full Text] [Related]

  • 35. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
    McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS.
    Proc Natl Acad Sci U S A; 1996 Sep 17; 93(19):10069-73. PubMed ID: 8816752
    [Abstract] [Full Text] [Related]

  • 36. Regulation of GRIP1 and CBP Coactivator activity by Rho GDI modulates estrogen receptor transcriptional enhancement.
    Su LF, Wang Z, Garabedian MJ.
    J Biol Chem; 2002 Oct 04; 277(40):37037-44. PubMed ID: 12138084
    [Abstract] [Full Text] [Related]

  • 37. Src-regulated extracellular signal-related kinase and Syk-regulated c-Jun N-terminal kinase pathways act in conjunction to induce IL-1 synthesis in response to microtubule disruption in HL60 cells.
    Cambien B, Millet MA, Schmid-Antomarchi H, Brossette N, Rossi B, Schmid-Alliana A.
    J Immunol; 1999 Nov 01; 163(9):5079-85. PubMed ID: 10528214
    [Abstract] [Full Text] [Related]

  • 38. Acute effects of interferon on estrogen receptor function do not involve the extracellular signal-regulated kinases p42mapk and p44mapk.
    Flint AP, Abayasekara DR, Wheeler-Jones CP, Riley PR, Kaluz S, Kaluzova M, Sheldrick EL, Fisher PA.
    J Interferon Cytokine Res; 2000 Feb 01; 20(2):225-33. PubMed ID: 10714559
    [Abstract] [Full Text] [Related]

  • 39. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.
    Ko L, Cardona GR, Chin WW.
    Proc Natl Acad Sci U S A; 2000 May 23; 97(11):6212-7. PubMed ID: 10823961
    [Abstract] [Full Text] [Related]

  • 40. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1.
    Tremblay A, Tremblay GB, Labrie F, Giguère V.
    Mol Cell; 1999 Apr 23; 3(4):513-9. PubMed ID: 10230404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.